procainamide hci

Generic: procainamide hci

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name procainamide hci
Generic Name procainamide hci
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

procainamide hydrochloride 100 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1334
Product ID 51662-1334_11c18bb0-a2ec-54f0-e063-6294a90a57c3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA089069
Listing Expiration 2026-12-31
Marketing Start 2019-02-10

Pharmacologic Class

Classes
antiarrhythmic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621334
Hyphenated Format 51662-1334

Supplemental Identifiers

RxCUI
857886
UNII
SI4064O0LX

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name procainamide hci (source: ndc)
Generic Name procainamide hci (source: ndc)
Application Number ANDA089069 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1334-1) / 10 mL in 1 VIAL, MULTI-DOSE
  • 25 POUCH in 1 BOX (51662-1334-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1334-2) / 10 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (2)

51662-1334-1 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1334-1) / 10 mL in 1 VIAL, MULTI-DOSE 51662-1334-3 25 POUCH in 1 BOX (51662-1334-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1334-2) / 10 mL in 1 VIAL, MULTI-DOSE

Ingredients (1)

procainamide hydrochloride (100 mg/mL)

Linked Drug Pages (1)

PROCAINAMIDE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "11c18bb0-a2ec-54f0-e063-6294a90a57c3", "openfda": {"unii": ["SI4064O0LX"], "rxcui": ["857886"], "spl_set_id": ["8192d79d-da2b-2532-e053-2991aa0ae8ad"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (51662-1334-1)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1334-1", "marketing_start_date": "20190210"}, {"sample": false, "description": "25 POUCH in 1 BOX (51662-1334-3)  / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1334-2)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1334-3", "marketing_start_date": "20220315"}], "brand_name": "PROCAINAMIDE HCI", "product_id": "51662-1334_11c18bb0-a2ec-54f0-e063-6294a90a57c3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]"], "product_ndc": "51662-1334", "generic_name": "PROCAINAMIDE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROCAINAMIDE HCI", "active_ingredients": [{"name": "PROCAINAMIDE HYDROCHLORIDE", "strength": "100 mg/mL"}], "application_number": "ANDA089069", "marketing_category": "ANDA", "marketing_start_date": "20190210", "listing_expiration_date": "20261231"}